Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70241 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Kavya Balusu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic, Influenza, Human. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyper‐inflammatory condition that can be triggered by viral infections. However, influenza is not commonly recognized as a cause of HLH, and there is no comprehensive synthesis of influenza‐associated HLH in the literature to guide clinicians. We conducted a systematic search of Pubmed and Embase to identify case reports and case series on influenza‐associated HLH, and included 29 articles involving 47 patients. Their age ranged from 2 months to 72 years. 67% were males. Influenza A accounted for 91.3% of the cases, predominantly H1N1 (90.2%). All patients had fever, 60% had anemia, 69.7% had thrombocytopenia, 46.6% had leukopenia, 61.3% had splenomegaly, 71.4% had hypertriglyceridemia, and 94.7% had elevated ferritin levels. 97.6% had hemophagocytosis on biopsy. Antiviral therapy was administered in 89.5% of patients. HLH‐directed therapy included corticosteroids (77%), intravenous immunoglobulin (36%), and etoposide (23.1%). Intensive care was required in 95.2% of cases. Overall survival was 53.2%. Survival rate was 50% among patients who received either antiviral therapy alone or HLH‐directed therapy alone, compared with 65.4% among those who received both. Further studies are necessary to establish standardized diagnostic and therapeutic protocols for influenza‐associated HLH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
- Department of Hospital Medicine, Washington University, St. Louis, Missouri, USA.
- Department of Hematology, Rochester General Hospital, Rochester, New York, USA.
ORCID-Profile: Kavya Balusu
Zitieren
APA
Balusu, K., Abdelhay, A., Payal, F., & Kouides, P. (2026). Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series. European Journal of Haematology. https://doi.org/10.1111/ejh.70241
Vancouver
Balusu K, Abdelhay A, Payal F, Kouides P. Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series. European Journal of Haematology. 2026. doi:10.1111/ejh.70241
BibTeX
@article{Balusu2026,
author = {Balusu, Kavya and Abdelhay, Ali and Payal, Fnu and Kouides, Peter},
title = {Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70241}
}
EUVIMED